Heterocyclic compounds useful as Pim kinase inhibitors
申请人:Incyte Corporation
公开号:US10450296B2
公开(公告)日:2019-10-22
The present application is concerned with heterocyclic compounds that inhibit the activity of Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancers and other diseases.
HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS
申请人:Incyte Corporation
公开号:US20170096411A1
公开(公告)日:2017-04-06
The present application is concerned with heterocyclic compounds that inhibit the activity of Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancers and other diseases.
US9920032B2
申请人:——
公开号:US9920032B2
公开(公告)日:2018-03-20
[EN] HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILES EN TANT QU'INHIBITEURS DE LA KINASE PIM
申请人:INCYTE CORP
公开号:WO2017059251A1
公开(公告)日:2017-04-06
The present application is concerned with heterocyclic compounds that inhibit the activity of Pim kinases and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancers and other diseases.